Page 2 - Area Middle East News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Medtronic Labs Philips Therapeutics Royal Danish Embassy. Considering the economic vulnerabilities faced by many of the patients living with diabetes in the country, the Affordability initiative seeks to ensure affordable insulins supplied reach patients. This will ultimately reach more people with quality care and treatments, and empower people with diabetes to better manage their condition while at the same time building the capacity of health care workers. Speaking at the launch of the initiative in Nairobi, Emil Larsen, CVP Business Area Middle East, Africa and CIS of Novo Nordisk said, “The main objective of the initiative is to accelerate access to affordable treatment for patients living with diabetes in Africa in a sustainable manner in four key areas. These are capacity, affordability, reach and empowerment thus ensuring more patients will be treated to defeat diabetes in Middle Africa, especially at this time of the celebration of 100 years of the discovery of Insulin

Nairobi areaAnyang nyongoEmil larsenEphantus mareeMinistry of healthKenya diabetes study groupAffordability initiativeCommunicable diseases alliance of kenyaMission for essential drugsChristian health association of kenyaKenya defeat diabetes associationRoyal danish embassyNovo nordiskKenya health information systemHealth associationEssential drugs